Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05391503 · ClinicalTrials.gov registry record · NA
Light Therapy for Obsessive-compulsive Disorder (OCD)
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05391503 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 21 participants.
The verdict
NCT05391503, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of a light-based circadian treatment on OCD symptoms in adults with OCD and late bedtimes. This study will have important implications for understanding the role of circadian rhythms in the etiology and treatment of OCD.
Interventions
- BEHAVIORAL Light therapy
- BEHAVIORAL Placebo light therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-09-23 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05391503
The ClinicalTrials.gov registry entry for NCT05391503 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Light therapy is the first listed.
NCT05391503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05391503 about?
NCT05391503 is a clinical study titled "Light Therapy for Obsessive-compulsive Disorder (OCD)". The purpose of this study is to examine the effect of a light-based circadian treatment on OCD symptoms in adults with OCD and late bedtimes. This study will have important implications for understanding the role of circadian rhythms in the etiology and treatment of OCD.
What is the current status of trial NCT05391503?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-09-23. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT05391503?
The interventions under investigation include: Light therapy (BEHAVIORAL), Placebo light therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05391503?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.